The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat

Abstract Aim This study investigates the effects of montelukast sodium (MK) (CysLTLT1 receptor antagonist) on CCl 4 induced hepatopathy on rat. Material and methods We worked on 4 groups of 10 Wistar male rats each. The groups received as follows: group I (control group) – saline, group II – MK 5 mg/kg/day i.p. for 5 days, group III – MK 5 mg/kg/day i.p., 1 day prior to and 4 days concomitantly with CCl 4 p.o., 0.3 ml/Kg/day and group IV – CCl 4 , p.o., 0.3 ml/Kg/day for 4 days. One day after the last administration, samples of blood were taken and alanine aminotransferase (ALT), total bilirubin (TB), direct bilirubin (DB), malondialdehyde (MDA), catalase (CAT) as well as total antioxidant capacity (TAC) were determined. The histopathological exam was performed. We also determined superoxide dismutase (SOD), MDA, CAT and GSH in liver homogenate. Results Compared to group IV, group III exhibited statistically significant lower levels of ALT (318 ± 15.75 versus 203.14 ± 10.28 UI, p p p  = 0.0004) and higher levels of SOD and CAT. Histopathologically, group IV presented important macro- and micro-vesicular hepatic steatosis and group III preserved lobular histoarchitecture and had less severe cellular lesions. Conclusion MK exhibits a partial hepatoprotective effect on rats treated with CCl 4 .